IN VIVO EFFICACY OF NY-ESO-1 PLUS ADJUVANT

• 收藏
• 分享

专利权人:

Ludwig Institute for Cancer Research;CSL Limited

发明人:

Jonathan Cebon,Ian Davis,Weisan Chen,Simon Green

申请号：

US14698237

公开号：

US20160000894A1

申请日:

2015.04.28

申请国别(地区):

US

年份:

2016

代理人:

摘要：

The invention relates to the discovery that administration of NY-ESO-1 protein, in combination with a saponin based adjuvant leads to an unexpectedly strong immune response against NY-ESO-1 expressing cells. Preferably, the combination is administered intramuscularly.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/